서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 12 of 12

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2012-08	Heterogeneity of genetic changes associated with acquired crizotinib resistance in Anaplastic lymphoma kinase-rearranged lung cancer 김소연	view file
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2013-09	Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment Huang, Donghui; Kim, Dong-Wan; Kotsakis, Athanasios; Deng, Shibing; Lira, Paul; Ho, Steffan N.; Lee, Nathan V.; Vizcarra, Pamela; Cao, Joan Q.; Christensen, James G.; Kim, Tae Min; Sun, Jong-mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Mao, Mao Genomics, Vol.102 No.3, pp.157-162	DOI
2014-08	Everolimus in combination with crizotinib synergistically inhibits the growth of ALK-positive anaplastic large cell lymphoma cells 허문단	view file
2014-11	Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non-Small-Cell Lung Cancer Blackhall, Fiona; Kim, Dong-Wan; Besse, Benjamin; Nokihara, Hiroshi; Han, Ji-Youn; Wilner, Keith D.; Reisman, Arlene; Iyer, Shrividya; Hirsh, Vera; Shaw, Alice T. Journal of Thoracic Oncology, Vol.9 No.11, pp.1625-1633	DOI
2016-08	Combined cetuximab and pemetrexed therapy enhances cytotoxicity against crizotinib resistant non-small cell lung cancer cells by downregulating thymidylate synthase 김혜진	view file
2018-07	Crizotinib versus chemotherapy in asian patients with alk-positive advanced non-small cell lung cancer Nishio, Makoto; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Solomon, Benjamin J.; Shaw, Alice T.; Hashigaki, Satoshi; Ohki, Emiko; Usari, Tiziana; Paolini, Jolanda; Polli, Anna; Wilner, Keith D.; Mok, Tony Cancer Research and Treatment, Vol.50 No.3, pp.691-700	view file DOI
2019-09	Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer Ock, Chan-Young; Yoo, Shin-Hye; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong Wan; Chung, Doo Hyun; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.34 No.5, pp.1116-1124	view file DOI
2021-12	Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Campelo, D. h Maria Rosario Garcia; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander I.; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Liu, Yuyin; Vranceanu, Florin; Niu, Huifeng; Zhang, Pingkuan; Popat, Sanjay Journal of Thoracic Oncology, Vol.16 No.12, pp.2091-2108	DOI
2022-09	Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials Gettinger, Scott N.; Huber, Rudolf M.; Kim, Dong-Wan; Bazhenova, Lyudmila; Hansen, Karin Holmskov; Tiseo, Marcello; Langer, Corey J.; Paz-Ares Rodríguez, Luis G.; West, Howard L.; Reckamp, Karen L.; Weiss, Glen J.; Smit, Egbert F.; Hochmair, Maximilian J.; Kim, Sang-We; Ahn, Myung-Ju; Kim, Edward S.; Groen, Harry J.M.; Pye, Joanna; Liu, Yuyin; Zhang, Pingkuan; Vranceanu, Florin; Camidge, D. Ross JTO Clinical and Research Reports, Vol.3 No.9, p. 100385	DOI
2022-10	Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC Wu, Yi-Long; Lu, Shun; Yang, James Chih-Hsin; Zhou, Jianying; Seto, Takashi; Ahn, Myung-Ju; Su, Wu-Chou; Yamamoto, Noboru; Kim, Dong-Wan; Paolini, Jolanda; Usari, Tiziana; Iadeluca, Laura; Wilner, Keith D.; Goto, Koichi JTO Clinical and Research Reports, Vol.3 No.10, p. 100406	DOI
2022-12	Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer Mazieres, Julien; Iadeluca, Laura; Shaw, Alice T.; Solomon, Benjamin J.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Kim, Dong-Wan; Mok, Tony; Reisman, Arlene; Thurm, Holger; Polli, Anna M.; Liu, Geoffrey Lung Cancer, Vol.174, pp.146-156	DOI

1